Implantable tachyarrhythmia control system having a patch electrode with an integrated cardiac activity system

• US 5,109,842 A
• Filed: 09/24/1990
• Issued: 05/05/1992
• Est. Priority Date: 09/24/1990
• Status: Expired due to Term

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Siemens Pacesetter, Inc. (Abbott Laboratories Incorporated)
• Inventors: Adinolfi, David W.
• Primary Examiner(s): Kamm, William E.
• Assistant Examiner(s): Getzow, Scott M.
• Application Number:
  US07/587,282
• Time in Patent Office: 589 Days
• Field of Search: 128/419 P, 128/419 D, 128/642, 128/784
• US Class Current: 607/2
• CPC Class Codes: A61N 1/0587 Epicardial electrode systems; Endocardial electrodes piercing the pericardium
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

An implantable tachyarrhythmia control system includes a patch electrode having a sensor integrated therein, such as a piezoelectric sensor, which is capable of monitoring mechanical heart activity. When the patch electrode is sutured to the cardiac tissue, the piezoelectric sensor will be deformed due to the mechanical activity of the heart muscle, and will generate a corresponding electrical signal. The electrical signal from the sensor will exhibit relatively low-frequency periodicity and relatively low amplitude during normal heart activity. In the event of tachycardia or fibrillation, the signal will exhibit excursions beyond those occurring for normal heart activity, and will consequently have a higher energy content. The signal is thus an indicator for the onset of these cardiac events. The signal can be supplied to an implantable defibrillator and can be used as a primary or secondary trigger for initiating defibrillation therapy, such as one or more defibrillating pulses. The signal may alternatively be supplied to an implantable combination pacemaker/defibrillator, which also undertakes standard R-wave detection via a conventional pacing lead. The signal from the patch electrode sensor can be used as before as a primary or secondary trigger to initiate defibrillation therapy alone or in combination with the detected R-wave signal. The patch sensor signal may also be used, alone or in combination with the R-wave signal, to initiate a change in the pacing mode or to initiate a particular pacing therapy, such as an antitachycardia sequence.

Claims

1. An implantable tachyarrhythmia control system comprising:

a flexible patch electrode adapted to be attached in vivo to cardiac tissue of a patient, said patch electrode including means for stimulating said cardiac tissue and having a motion sensor means embedded therein for generating an electrical signal corresponding to cardiac wall movement;

means adapted for in vivo electrical connection to said motion sensor means for analyzing said electrical signals to identify the presence of tachycardia;

means adapted for in vivo electrical connection to said means for stimulating, and electrically connected to said means for analyzing, for initiating therapeutic electrical treatment via said means for stimulating cardiac tissue upon the identification of tachyarrhythmia by said means for analyzing; and

a housing containing said means for analyzing and said means for initiating therapeutic electrical treatment adapted for implantation in said patient.

2. An implantable tachyarrhythmia control system as claimed in claim 1 wherein said motion sensor means is a piezoelectric sensor.

3. An implantable tachyarrhythmia control system as claimed in claim 1 wherein said means for analyzing is a means for detecting the onset of fibrillation, wherein said means for initiating therapeutic electrical treatment is a means for generating electrical defibrillation therapy, and wherein said means for stimulating cardiac tissue is a means for delivering said defibrillating electrical therapy to said cardiac tissue.

4. An implantable tachyarrhythmia control system as claimed in claim 3 wherein said means for delivering defibrillating electrical therapy to said cardiac tissue is a wire mesh electrode contained in said patch electrode and adapted for direct contact with said cardiac tissue.

6. An implantable tachyarrhythmia control system as claimed in claim 1 further comprising:

a further flexible patch electrode adapted to be attached in vivo to cardiac tissue in a patient, said further patch electrode including further means for stimulating said cardiac tissue and having a further motion sensor means embedded therein for generating an electrical signal corresponding to cardiac wall movement, said means for analyzing being adapted for in vivo electrical connection to said further motion sensor means and said means for initiating therapeutic electrical treatment being adapted for in vivo electrical connection to said further means for stimulating cardiac tissue.

5. An implantable tachyarrhythmia control system as claimed in claim wherein said patch electrode further includes a cable containing electrical lines connecting said motion sensor means to said means for analyzing and said means for stimulating to said means for initiating therapeutic electrical treatment, and a carrier connected to said cable at terminal region of said carrier, said carrier having an electrode region in which said means for stimulating is disposed and a neck region, between said electrode region and said terminal region, in which said motion sensor means is disposed.

7. An implantable tachyarrhythmia control system comprising:

a first flexible patch electrode adapted to be attached in vivo to cardiac tissue, said first patch electrode including first means for stimulating said cardiac tissue and having a first motion sensor means embedded therein for generating a first electrical signal corresponding to cardiac wall movement;

a second flexible patch electrode adapted to be attached in vivo to said cardiac tissue, said second patch electrode including second means for stimulating said cardiac tissue and having a second motion sensor means embedded therein for generating a second electrical signal corresponding to cardiac wall movement;

means adapted for electrical connection in vivo to said first and second motion sensor means for analyzing said first and second electrical signals to identify the presence of tachyarrhythmia and for identifying which of said first or second electrical signals indicates the presence of tachycardia;

means adapted for in vivo electrical connection to said first and second means for stimulating, and electrically connected to said means for analyzing, for initiating therapeutic electrical treatment via one or both of said means for stimulating cardiac tissue upon the identification of tachycardia dependent upon which of said first or second electrical signals indicate the presence of tachycardia; and

a housing adapted for implantation in said patient and containing said means for analyzing and said means for initiating therapeutic electrical treatment.

8. An implantable tachyarrhythmia control system as claimed in claim 7 wherein each of said first and second motion sensor means is a piezoelectric sensor.

9. An implantable tachyarrhythmia control system as claimed in claim 7 wherein said means for analyzing is a means for detecting the presence of fibrillation, wherein said means for initiating therapeutic electrical treatment is a means for initiating electrical defibrillation therapy, and wherein said first and second means for stimulating are each means for delivering said electrical defibrillation therapy to said cardiac tissue.

10. An implantable tachyarrhythmia control system comprising:

means adapted to be attached in vivo to cardiac tissue for mechanical interaction with said cardiac tissue for generating a first electrical signal corresponding to mechanical cardiac activity;

means adapted to be placed in contact in vivo with said cardiac tissue for electrical interaction with said cardiac tissue for generating a second electrical signal corresponding to electrical cardiac activity;

means adapted for in vivo electrical connection to said means for mechanical interaction with said cardiac tissue for analyzing said first electrical signal to identify the presence of tachyarrhythmia;

means adapted for in vivo electrical connection to said means for electrical interaction with said cardiac tissue for analyzing said second electrical signal to identify the presence of tachyarrhythmia;

means adapted for in vivo contact with said cardiac tissue for electrically stimulating said cardiac tissue;

means adapted for in vivo connection to said means for stimulating, and electrically connected to each of said means for analyzing said first and second electrical signals, for initiating therapeutic electrical treatment via said means for stimulating cardiac tissue upon the identification of tachyarrhythmia; and

a housing adapted for implantation in said patient and containing said means for analyzing said first electrical signal, said means for analyzing said second electrical signal, and said means for initiating therapeutic electrical treatment.

11. An implantable tachyarrhythmia control system as claimed in claim 10 wherein said means for analyzing said first electrical signal is a means for analyzing said first electrical signal for identifying the presence and type of tachycardia, wherein said means for analyzing said second electrical signal is a means for analyzing second electrical signal to identify the presence and the type of tachycardia, wherein said means for stimulating said cardiac tissue includes means adapted for delivering high energy therapeutic electrical treatment to said cardiac tissue and means adapted for delivering low energy therapeutic electrical treatment to said cardiac tissue and wherein said means for initiating therapeutic electrical treatment upon the identification of tachycardia includes means for selecting high or low energy therapeutic electrical treatment dependent on the type of tachycardia identified by each of said means for analyzing said first and second electrical signals.

12. An implantable tachyarrhythmia control system as claimed in claim 11 wherein said means adapted for delivering high energy therapeutic electrical treatment to said cardiac tissue is a defibrillator patch electrode, and wherein said means for mechanical interaction with said cardiac tissue is mounted in said patch electrode.

13. An implantable tachyarrhythmia control system as claimed in claim 11 wherein said means adapted for mechanical interaction with said cardiac tissue is a piezoelectric sensor adapted for placement relative to said cardiac tissue for detecting cardiac wall movement.

14. An implantable tachyarrhythmia control system comprising:

a flexible patch electrode adapted to be attached in vivo to cardiac tissue of a patient, said electrode including means for stimulating said cardiac tissue with defibrillating electrical therapy and first sensor means adapted for mechanical interaction with said cardiac tissue for generating a first signal indicative of mechanical cardiac activity;

a pacing lead including means for stimulating said cardiac tissue with pacemaking electrical therapy and second sensor means adapted for electrical interaction with said cardiac tissue for generating a second signal indicative of electrical cardiac activity;

first therapy means adapted for in vivo electrical connection to said means for stimulating in said pacing lead for generating electrical pacing pulses in an antitachycardia sequence;

second therapy means adapted for in vivo electrical connection to said means for stimulating in said patch electrode for generating electrical cardioversion or defibrillating pulses;

first logic means adapted for in vivo electrical connection to said first sensor means for analyzing said first signal to identify, in an output signal of said first logic means, the presence of tachycardia or fibrillation;

second logic means adapted for in vivo electrical connection to said second sensor means for analyzing said second signal to identify, in an output signal of said second logic means, at least the presence of tachycardia;

means for logically combining the respective output signals of said first and second logic means;

control logic means to which the respective output signals of each of said first and second logic means and said means for logically combining are supplied, and connected to said first and second therapy means, for initiating an electrical therapy by enabling one of said first or second therapy means dependent on whether said output signals indicate the presence of tachycardia or fibrillation;

a housing adapted for implantation in said patient containing said first and second therapy means, said first and second logic means, said means for logically combining, and said control logic means.

15. An implantable tachyarrhythmia control system as claimed in claim 14 further comprising:

third therapy means, contained in said housing and adapted for in vivo electrical connection to said means for stimulating in said pacing lead, for generating pacemaking pulses in a sequence for treatment of bradycardia, said third therapy means being connected to said control logic means and being enabled by said control logic means in the absence of tachycardia or fibrillation.

16. An implantable tachyarrhythmia control system as claimed in claim 14 further comprising:

means for telemetrically programming said control logic means for selecting any one, or any combination, of said output signals of said first and second logic means and said means for logically combining as the basis for initiating said electrical therapy.

17. An implantable tachyarrhythmia control system as claimed in claim 14 wherein said means for logically combining is an AND gate.

18. An implantable tachyarrhythmia control system as claimed in claim 14 wherein said second logic means is an R-wave detection circuit.

19. An implantable tachyarrhythmia control system as claimed in claim 14 wherein said means for mechanically interacting with said cardiac tissue is a piezoelectric sensor.

20. A defibrillator patch electrode comprising:

means adapted for in vivo contact with cardiac tissue for delivering defibrillating electrical energy to said cardiac tissue; and

means adapted for mechanically interacting with said cardiac tissue for generating an electrical signal corresponding to mechanical activity of said cardiac tissue.

21. A patch electrode as claimed in claim 20 wherein said means for mechanically interacting with said cardiac tissue is a piezoelectric sensor.

22. A patch electrode as claimed in claim 21 wherein said piezoelectric sensor comprises:

a metallic backing; and

a piezoelectric crystal attached to said metallic backing.

23. A patch electrode as claimed in claim 22 wherein said metallic backing consists of titanium.

24. A defibrillating patch electrode comprising:

a carrier having an electrode region, a terminal region adapted for mechanical and electrical connection to an electrical cable, and a neck region disposed between said electrode region and said terminal region;

means disposed in said electrode region adapted for in vivo contact with cardiac tissue for delivering defibrillating electrical energy to said cardiac tissue; and

means disposed in said neck region for mechanically interacting with said cardiac tissue for generating an electrical signal corresponding to mechanical activity of said cardiac tissue.

25. A patch electrode as claimed in claim 24 wherein said means for mechanically interacting with said cardiac tissue is a piezoelectric sensor.

26. A patch electrode as claimed in claim 24 wherein said electrode region has a figure-eight shape formed by two lobes joined by a narrow region, and wherein said neck region is disposed at a side of one of said lobes closest to said narrow region.

27. A patch electrode as claimed in claim 24 wherein said electrode region has a figure-eight shape formed by two lobes joined by a narrow region, and wherein said neck region is disposed at a side of one of said lobes farthest from said narrow region.

28. A patch electrode as claimed in claim 24 wherein said electrode region has a rabbit ear shape formed by two lobes with a narrow region therebetween, and wherein said neck region of said carrier is adjacent said narrow region.

29. A patch electrode as claimed in claim 24 wherein said electrode region is triangular, and wherein said neck region is disposed at an apex of said electrode region.

30. A patch electrode as claimed in claim 29 wherein said electrode region is in the shape of an isosceles triangle, and wherein said neck region is disposed at an apex of said isosceles triangle at which sides of equal length meet.

31. A patch electrode as claimed in claim 24 further comprising:

first and second electrical leads for said means for mechanically interacting with said cardiac tissue;

a third electrical lead for said means for delivering defibrillating electrical energy; and

a cable extending from said carrier and containing all of said first, second and third leads, said cable terminating in a first branch containing said first and second leads and a terminal assembly therefor, and a second branch containing only said third lead and a terminal assembly therefor.

32. A patch electrode as claimed in claim 24 further comprising:

first and second electrical leads for said means for mechanically interacting with said cardiac tissue;

a third electrical lead for said means for delivering defibrillating electrical energy, said first lead being electrically connected in said carrier to said third lead; and

a cable extending from said carrier containing said second and third leads and terminating in a single terminal assembly.

33. A patch electrode as claimed in claim 24 wherein said carrier has a surface thereof adapted for in vivo contact with said cardiac tissue, and wherein said means for mechanically interacting with said cardiac tissue is disposed adjacent said surface.

34. A patch electrode as claimed in claim 24 wherein said carrier has a surface adapted to face away in vivo from said cardiac tissue, and wherein said means for mechanically interacting with said cardiac tissue is disposed adjacent said surface.

35. A method for treating fibrillation in a patient comprising the steps of:

attaching a defibrillator patch electrode to cardiac tissue;

mounting a sensor in said patch electrode for detecting mechanical activity of said cardiac tissue and generating an electrical signal corresponding to said mechanical activity;

monitoring said electrical signal to identify characteristics of said electrical signal indicating the presence of fibrillation; and

undertaking defibrillation therapy by applying electrical energy to said cardiac tissue via said patch electrode when said characteristics indicating fibrillation are present in said electrical signal.

36. A method as claimed in claim 35 wherein said electrical signal also includes characteristics indicating the presence of tachycardia, and comprising the additional steps of:

placing a pacing electrode in contact with said cardiac tissue for delivery of pacemaking pulses to said cardiac tissue;

monitoring said electrical signal to identify said characteristics therein indicating the presence of tachycardia; and

initiating an antitachycardia pacing sequence via said pacing electrode upon the identification of said characteristics in said electrical signal indicating tachycardia.

37. A method as claimed in claim 36 comprising the additional step of:

administering a bradycardia pacing sequence to said cardiac tissue via said pacing electrode in the absence of characteristics in said electrical signal indicating tachycardia or fibrillation.